Welcome to our dedicated page for GLOBE LIFE SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported an exercise-and-sell pattern in company stock. He exercised options to acquire a total of 15,000 shares of common stock at an exercise price of $100.74 per share, then sold 15,000 shares in open-market transactions at prices around $153–$154 per share.
After these transactions, he holds 54,020.4648 shares of common stock directly. He also has indirect holdings through retirement and trust accounts, including shares held in a 401(k) Plan, a spouse's irrevocable trust, an irrevocable trust, and a Family Trust.
GLOBE LIFE INC. Co-Chairman & CEO James Matthew Darden reported option exercises and share sales in Globe Life common stock. On May 5, 2026, he exercised employee stock options to acquire 22,019 shares at an exercise price of $100.74 per share.
That same day, he executed open-market sales totaling 22,019 shares, including 9,114 shares at an average price of $154.2904 and 12,905 shares at an average price of $153.5323. Following these transactions, he holds 67,565.4598 shares directly and 4,194.479 shares indirectly through a 401(k) plan.
Globe Life Inc Schedule 13G shows Invesco Ltd. reports beneficial ownership of 4,016,350 shares of Globe Life common stock, representing 5.1% of the class as of 03/31/2026. The filing states sole voting power of 3,983,660 shares and sole dispositive power of 4,016,350 shares, and lists Invesco subsidiaries that hold the position on behalf of clients.
Globe Life Inc. Co-Chairman & CEO Frank M. Svoboda reported an option exercise and related share sales in company stock. He exercised 10,000 shares of common stock through employee stock options at a $100.74 exercise price per share.
On the same date, he executed open-market sales totaling 10,000 shares of common stock, including 8,720 shares at $153.6775 and 1,280 shares at $154.2262 per share, according to the filing footnotes. Following these transactions, he directly holds 55,300.4648 shares of Globe Life common stock.
The filing also lists indirect holdings in various trusts and plans, including 103,473 shares in a Family Trust and additional shares in an irrevocable trust, a spouse’s irrevocable trust, and a 401(k) plan as of the reported date.
Globe Life Inc. reported results of its April 30, 2026 annual shareholder meeting and board changes. Long‑serving directors Linda L. Addison and Marilyn A. Alexander retired from the Board at the meeting.
Shareholders elected 12 directors to one‑year terms, with each nominee receiving over 59 million votes in favor. They gave advisory approval to 2025 executive compensation, with 55,385,745 votes for and 6,887,045 against, and approved the Globe Life Inc. 2026 Incentive Plan with 57,917,710 votes for and 4,271,772 against. Deloitte & Touche LLP was ratified as independent auditor for 2026 with 67,622,465 votes for and 3,212,321 against. The company plans to include an annual shareholder vote on executive compensation in its proxy materials through 2029.
Vanguard Capital Management reported beneficial ownership of 5,847,224 shares of Globe Life Inc. common stock, representing 7.45% of the class as disclosed in a Schedule 13G.
The filing states Vanguard has sole voting power for 697,232 shares and sole dispositive power for 5,847,224 shares. The filing lists Globe Life's CUSIP 37959E102 and the reporting address for Vanguard Capital Management.
Globe Life Inc. Co-Chairman & CEO James Matthew Darden reported an option exercise and related share sale in company stock. On April 28, 2026, he exercised 4,663 Employee Stock Options at $100.74 per share and acquired the same number of common shares.
The same day, he executed an open-market sale of 4,663 common shares at an average price of about $153.88 per share, with sale prices ranging from $153.635 to $154.24. Following these transactions, he holds 58,451.4598 common shares directly and 4,185.5150 common shares indirectly through a 401(k) plan. He also retains 22,019 stock options after the exercise.
Vanguard Portfolio Management reported beneficial ownership of 4,269,535 shares of Globe Life Inc. common stock, representing 5.44% of the class. The filing shows sole voting power for 15,432 shares and sole dispositive power for 4,269,535 shares. The Form is signed by Ashley Grim on 04/29/2026.
Globe Life Inc. Co‑Chairman & CEO James Matthew Darden reported an option exercise and related share sale. He exercised 18,318 shares of common stock via employee stock options at $100.7400 per share, then completed an open‑market sale of 18,318 shares at an average price of $145.1029 per share.
Footnotes state the sale prices ranged from $145.00 to $145.275 per share. After these transactions, he directly holds 58,451.4598 shares of common stock, plus 4,185.5850 shares held indirectly through a 401(k) Plan, and 26,682 employee stock options remain outstanding.